SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-20-107108
Filing Date
2020-09-22
Accepted
2020-09-21 19:42:00
Documents
12
Period of Report
2020-09-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2031376-2_8ka.htm   iXBRL 8-K/A 27562
2 EXHIBIT 99.1 tm2031376d2_ex99-1.htm EX-99.1 22281
6 GRAPHIC tm2031376d2_ex99-1img01.jpg GRAPHIC 10524
  Complete submission text file 0001104659-20-107108.txt   247395

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA axsm-20200921.xsd EX-101.SCH 3180
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE axsm-20200921_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axsm-20200921_pre.xml EX-101.PRE 22706
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2031376-2_8ka_htm.xml XML 3725
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37635 | Film No.: 201187564
SIC: 2834 Pharmaceutical Preparations